Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Alkermes Stock (NASDAQ: ALKS) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 5.00 / 1.84M |
Day Range | - - - |
52 Wk Range | 22.01 - 32.88 |
Market Cap | $4.63B |
P/E Ratio | 12.32 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 57 |
Short Interest | 15.44% |
Days to Cover | 14.57 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Alkermes (NASDAQ:ALKS) through any online brokerage.
Other companies in Alkermes’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and Ionis Pharmaceuticals (NASDAQ:IONS).
Alkermes has a consensus price target of $34.63.
The stock price for Alkermes (NASDAQ: ALKS) is $28.1 last updated September 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Alkermes.
Alkermes’s Q3 earnings are confirmed for Wednesday, October 23, 2024.
There is no upcoming split for Alkermes.
Alkermes is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.